BravoVax

BravoVax is a China-based biotechnology company specializing in developing vaccines such as the multivalent rotavirus vaccine and pneumococcal conjugate vaccine. It has five technology platforms to conduct its research which include bacterial fermentation, cell and virus culture, purification, formulation and quality control and are equipped with advanced instruments (such as fluorescent quantitative polymerase chain reaction).

In 2020, the company partnered with GeoVax, an American biotechnology company, to collaborate on the development of a COVID-19 vaccine. The company's role in the partnership included further development of the vaccine developed by its partner, including testing and manufacturing, as well as directing interactions with Chinese health authorities.